PHARMACOPSYCHIATRY

PHARMACOPSYCHIATRY

PHARMACOPSYCHIATRY期刊
PHARMACOPSYCHIATRY
影响因子:2.2
JCR分区:Q3
新锐分区:医学3区
是否综述期刊:N/A
是否预警:不在预警名单内
是否OA:
出版国家/地区:GERMANY
出版社:Georg Thieme Verlag
发刊时间:1984
收录数据库:SCIE/Scopus收录
ISSN:0176-3679

期刊介绍

Covering advances in the fi eld of psychotropic drugs, Pharmaco psychiatry provides psychiatrists, neuroscientists and clinicians with key clinical insights and describes new avenues of research and treatment. The pharmacological and neurobiological bases of psychiatric disorders are discussed by presenting clinical and experimental research.
PHARMACOPSYCHIATRY期刊《药物精神病学》涵盖了精神药物领域的进展,为精神病学家、神经科学家和临床医生提供了关键的临床见解,并描述了研究和治疗的新途径。通过临床和实验研究讨论精神障碍的药理学和神经生物学基础。
年发文量 40
国人发稿量 0.8
国人发文占比 0.02%
自引率 9.1%
平均录取率较易
平均审稿周期 较慢,6-12周
版面费 -
偏重研究方向 医学-精神病学

期刊高被引文献

Combination of Metformin and Lifestyle Intervention for Antipsychotic-Related Weight Gain: A Meta-Analysis of Randomized Controlled Trials.
来源期刊:PharmacopsychiatryDOI:10.1055/s-0044-101466
Efficacy, Tolerability, and Safety of Blonanserin in Schizophrenia: An Updated and Extended Systematic Review and Meta-Analysis of Randomized Controlled Trials.
来源期刊:PharmacopsychiatryDOI:10.1055/a-0574-0088
QTc Time Correlates with Amitriptyline and Venlafaxine Serum Levels in Elderly Psychiatric Inpatients.
来源期刊:PharmacopsychiatryDOI:10.1055/s-0044-102009
No Connection between Long-Term Lithium Treatment and Antithyroid Antibodies.
来源期刊:PharmacopsychiatryDOI:10.1055/a-0838-6062
Algorithms For Treatment of Major Depressive Disorder: Efficacy and Cost-Effectiveness.
来源期刊:PharmacopsychiatryDOI:10.1055/a-0643-4830
Clinical Utilization of Pharmacogenetics in Psychiatry - Perspectives of Pharmacists, Genetic Counselors, Implementation Science, Clinicians, and Industry.
来源期刊:PharmacopsychiatryDOI:10.1055/a-0975-9595
Comparative Efficacy and Safety of Antipsychotic Drugs for Tic Disorders: A Systematic Review and Bayesian Network Meta-Analysis.
来源期刊:PharmacopsychiatryDOI:10.1055/s-0043-124872
Peripheral Oxytocin Predicts Higher-Level Social Cognition in Men Regardless of Empathy Quotient.
来源期刊:PharmacopsychiatryDOI:10.1055/a-0590-4850
Fat Mass and Obesity-Related Gene Variants rs9939609 and rs7185735 are Associated with Second-Generation Antipsychotic-Induced Weight Gain.
来源期刊:PharmacopsychiatryDOI:10.1055/s-0043-125392
Commercial Pharmacogenetic Tests in Psychiatry: Do they Facilitate the Implementation of Pharmacogenetic Dosing Guidelines?
来源期刊:PharmacopsychiatryDOI:10.1055/a-0863-4692
The Role of Dietary Supplements in Depression and Anxiety - A Narrative Review.
来源期刊:PharmacopsychiatryDOI:10.1055/a-0942-1875
The Effects of Co-prescription of Pantoprazole on the Clozapine Metabolism.
来源期刊:PharmacopsychiatryDOI:10.1055/a-1021-8827
What Does Antidepressant Drug level Monitoring Reveal About Outpatient Treatment and Patient Adherence?
来源期刊:PharmacopsychiatryDOI:10.1055/s-0044-101838
Hypothalamic-Pituitary-Adrenocortical Axis Activity in Alcohol-Dependent Patients During Treatment with High-Dose Baclofen.
来源期刊:PharmacopsychiatryDOI:10.1055/s-0043-124189
Acute and Long-term Memantine Add-on Treatment to Risperidone Improves Cognitive Dysfunction in Patients with Acute and Chronic Schizophrenia.
来源期刊:PharmacopsychiatryDOI:10.1055/a-0970-9310
Clozapine-Induced DRESS Syndrome: A Case Series From the AMSP Multicenter Drug Safety Surveillance Project.
来源期刊:PharmacopsychiatryDOI:10.1055/a-0586-8983
Hippocampal Dysfunction in Schizophrenia and Aberrant Hippocampal Synaptic Plasticity in Rodent Model Psychosis: a Selective Review.
来源期刊:PharmacopsychiatryDOI:10.1055/a-0960-9846
From the Origins of Pharmacogenetics to First Applications in Psychiatry.
来源期刊:PharmacopsychiatryDOI:10.1055/a-0979-2322
Impact of Chronic Cannabis Use on Auditory Mismatch Negativity Generation in Schizophrenia Patients.
来源期刊:PharmacopsychiatryDOI:10.1055/a-0573-9866
Correlation Between Violence and Antipsychotic Dosage in Schizophrenia: A Secondary Analysis of The Clinical Antipsychotic Trials for Intervention Effectiveness (CATIE) Dataset.
来源期刊:PharmacopsychiatryDOI:10.1055/a-0826-4935
Antidepressant Prescription and Risk of Lung Cancer: A Nationwide Case-Control Study.
来源期刊:PharmacopsychiatryDOI:10.1055/a-0596-0819
Ketamine in the Treatment of Depressive Episodes.
来源期刊:PharmacopsychiatryDOI:10.1055/a-0991-0582
Pathological Concentration of C-reactive Protein is Correlated to Increased Concentrations of Quetiapine, But Not of Risperidone, Olanzapine and Aripiprazole in a Naturalistic Setting.
来源期刊:PharmacopsychiatryDOI:10.1055/a-0869-8053
Treatment of the Neuroleptic Malignant Syndrome in International Therapy Guidelines: a Comparative Analysis.
来源期刊:PharmacopsychiatryDOI:10.1055/a-1046-1044
Circadian Clocks in the Regulation of Neurotransmitter Systems.
来源期刊:PharmacopsychiatryDOI:10.1055/a-1027-7055
Roadmap for Routine Pharmacogenetic Testing in a Psychiatric University Hospital.
来源期刊:PharmacopsychiatryDOI:10.1055/a-0914-3234
Comparison of International Therapy Guidelines with Regard to the Treatment of Malignant Catatonia.
来源期刊:PharmacopsychiatryDOI:10.1055/a-1007-1949
Very Low Frequency of Drug Therapy of Alcohol Dependence in Germany - Analysis of Data of A Statutory Health Insurance.
来源期刊:PharmacopsychiatryDOI:10.1055/a-0896-2757
Retrospective Analysis of Risk Factors for Periodic Limb Movements in a Large Cohort of Insomnia and Chronic Fatigue Patients.
来源期刊:PharmacopsychiatryDOI:10.1055/a-0991-0498
Consider Role of Glutamatergic Habenula-projecting Globus Pallidus in OCD.
来源期刊:PharmacopsychiatryDOI:10.1055/a-0835-6447
Response to Agomelatine Treatment is Independent of Smoking Status and Dosage: Results From the AGOPSYCH Study.
来源期刊:PharmacopsychiatryDOI:10.1055/a-0606-5240
Evaluation of Myocardial Damage After Electroconvulsive Therapy: Analyses of High-Sensitive Cardiac Troponin I and N-Terminal pro-B-type Natriuretic Peptide.
来源期刊:PharmacopsychiatryDOI:10.1055/a-0646-4278
Adjunctive Reboxetine for Schizophrenia: Meta-analysis of Randomized Double-blind, Placebo-controlled Trials.
来源期刊:PharmacopsychiatryDOI:10.1055/a-0914-3260
8-Hydroxylation and Glucuronidation of Mirtazapine in Japanese Psychiatric Patients: Significance of the Glucuronidation Pathway of 8-Hydroxy-Mirtazapine.
来源期刊:PharmacopsychiatryDOI:10.1055/a-0918-6408

质量指标占比

研究类文章占比 OA被引用占比 撤稿占比 出版后修正文章占比
85.00%20.93%-2.56%

相关指数

影响因子
影响因子
年发文量
自引率

预警情况

查看说明
时间 预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
*来源:中科院《 国际期刊预警名单》

JCR分区

WOS分区等级:3区
版本 按学科 分区
WOS期刊SCI分区
WOS期刊SCI分区
WOS期刊SCI分区是指SCI官方(Web of Science)为每个学科内的期刊按照IF数值排 序,将期刊按照四等分的方法划分的Q1-Q4等级,Q1代表质量最高,即常说的1区期刊。
(2024-2025年最新版)
PHARMACOLOGY & PHARMACY
Q3
PSYCHIATRY
Q3

中科院分区

查看说明
版本 大类学科 小类学科 Top期刊 综述期刊
2026年3月发布
(新锐分区)
医学3区
PHARMACOLOGY & PHARMACY 药学
3区
PSYCHIATRY 精神病学
4区
N/A
2025年3月升级版
医学4区
PHARMACOLOGY & PHARMACY 药学
4区
PSYCHIATRY 精神病学
4区
2023年12月旧的升级版
医学3区
PHARMACOLOGY & PHARMACY 药学
3区
PSYCHIATRY 精神病学
4区

CiteScore

查看说明
CiteScore SJR SNIP 学科 分区 排名
9.00
0.943
1.204
大类:Medicine 小类:Psychiatry and Mental Health
大类:Medicine 小类:Pharmacology (medical)
Q1
Q1
52 / 580
27 / 275

相关文章